WO1996010358A1 - Method and device at primarily electrogastrography and electrourography - Google Patents
Method and device at primarily electrogastrography and electrourography Download PDFInfo
- Publication number
- WO1996010358A1 WO1996010358A1 PCT/SE1995/001120 SE9501120W WO9610358A1 WO 1996010358 A1 WO1996010358 A1 WO 1996010358A1 SE 9501120 W SE9501120 W SE 9501120W WO 9610358 A1 WO9610358 A1 WO 9610358A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- signals
- patient
- impedance
- primarily
- bladder
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 230000002496 gastric effect Effects 0.000 claims abstract description 26
- 230000028161 membrane depolarization Effects 0.000 claims abstract description 13
- 230000000875 corresponding effect Effects 0.000 claims abstract description 9
- 230000002596 correlated effect Effects 0.000 claims abstract description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract 4
- 230000003202 urodynamic effect Effects 0.000 claims abstract 2
- 238000005259 measurement Methods 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 11
- 210000002784 stomach Anatomy 0.000 claims description 9
- 230000000291 postprandial effect Effects 0.000 claims description 7
- 230000005669 field effect Effects 0.000 claims description 3
- 206010021639 Incontinence Diseases 0.000 claims description 2
- 230000010287 polarization Effects 0.000 claims description 2
- 238000010223 real-time analysis Methods 0.000 claims description 2
- 230000005611 electricity Effects 0.000 claims 2
- 206010017943 Gastrointestinal conditions Diseases 0.000 claims 1
- 206010021518 Impaired gastric emptying Diseases 0.000 claims 1
- 210000003815 abdominal wall Anatomy 0.000 claims 1
- 230000002545 bradygastric effect Effects 0.000 claims 1
- 238000002593 electrical impedance tomography Methods 0.000 claims 1
- 208000001288 gastroparesis Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000001881 tachygastric effect Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 description 13
- 238000005070 sampling Methods 0.000 description 7
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 238000012552 review Methods 0.000 description 4
- 230000036263 tachygastria Effects 0.000 description 4
- 230000008602 contraction Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000030135 gastric motility Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- PCLIRWBVOVZTOK-UHFFFAOYSA-M 2-(1-methylpyrrolidin-1-ium-1-yl)ethyl 2-hydroxy-2,2-diphenylacetate;iodide Chemical compound [I-].C=1C=CC=CC=1C(O)(C=1C=CC=CC=1)C(=O)OCC[N+]1(C)CCCC1 PCLIRWBVOVZTOK-UHFFFAOYSA-M 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009177 electrical depolarization Effects 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/391—Electromyography [EMG] of genito-urinary organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/392—Detecting gastrointestinal contractions
Definitions
- the present invention relates a method for principally electrogast ⁇ rography (EGG) and electrourography (EUG) comprizing a measuring of principally rythmic depolarization signals of mainly a gastrointestinal origin or a vesical origin.
- the invention also relates to a device for perfo ⁇ iiing the method.
- Gastric depolarization signals normally occur with a frequency of about three cycles per minut. Other frequencies occur in other other parts. Some, but not all depolarization signals are considered to provoke gast ⁇ ric contractions, but all gastric contractions are considered, as also with EKG, to be preceded by electric depolarization signals. Inadequate depolarization signals might occur and it has proved that anormal signals occur with e.g. stomach suffering, such as indisposition, nervous bladder, incontinence, etc. Moreover, EGG presents thus a new way to achieve gastric motility with the advantage to be a noninvasive method to replace and/or complement other, more known methods, such as ultrasonics, gastric emptying, etc. Ambulatoric EGG can provide an easily usable, noninvasive and inexpensive method to analyse gastric activity e.g. in a domestic environment and can in the medical science facilitate a diag ⁇ nosis of gastric motility and to prescribe an adequate therapy.
- EUG is a new method for a noninvasive examination of the urinary bladder.
- the desciption is con ⁇ centrated to EGG, but all that may be stated in this respect is generally applicable even to EUG.
- EGG electrical cyclic signals from the stomach
- the present invention provides the possibility for an accurate EGG in such a way that a diagnosis can be achieved with essentially improved accuracy and stringency, the adaptation to research purposes thus being essentially increased.
- the improved diagnosis are, as is well known, en ⁇ tailing secondary advantages in form of a reduced convalescence, etc.
- the invention thus relates to a method according to the first part of claim 1.
- the method is especially characterized in what is stated in the characterizing part of said claim.
- the invention further relates to a device according to the first part of claim 8.
- the device is especially characterized in what is stated in the xharacterizing part of said last mentioned claim.
- Figure 1 schematically shows the general configuration of a preferred embodiment of a portable system for EGG data recording according to the invention
- Figure 2 shows a block diagram illustrating the overall logic circuit function of an EGG data recording device acccording to the invention.
- the portable EGG and analyzing system comprises a data recording device 10 connected to external lines 11 ending in impe ⁇ dance converting electrodes 20 which then are connected to to skin based readable electrodes 22, preferably to at least two.
- the recording device is accomplished as a modification of the Digitrapper Mklll for recording pH-data (available from Synectics Medical Inc., Irving, Texas).
- a set of four keys 12 are adapted to control the data recording device and to let the patient register periodical data for events during recording.
- a display 13 cooperates to service the device 10 by (1) showing a menue driven control system during the preparation and the analys of the recording and (2) showing the recorded data on line during recording.
- the impedance converting electrodes 20 comprize a field effect transistor circuit operating as an impedance converter with an amplifying factor 1.
- the electrodes 20 are connected to surface electrodes 22 placed on top of the patients stomach 23, small intestine, bladder, etc.
- the EGG or EUG signals are recorded and sent through said impedance converting electrodes 20 and further through said lines 11 to the data recording device 10.
- the device 10 When the EGG or EUG recording operations are completed, data are sent from the device 10 into a computer 15, e.g. a PC, to analyze the recorded gastric signals as to the gastric function and generates a report of analysis (not shown).
- a computer e.g. a PC
- the device 10 may comprise a computer for a corresponding handling of said data.
- the standard report shows a spectrum of variables calculated by means of a fast frequency conversion, FFT, of the EGG signals from e.g. three preprandial periods and three selected postprandial periods.
- the recording device is sampling EGG data with a sampling freequency of about 2Hz during recording. These data are used and each line of the spectrum of variables uses 512 samplings during each cycle of four minutes.
- the X-axis shows the cycles per minut and the Y-axis the variable.
- the Z-axis shows the time intervals.
- next line of four minutes is using both the samplings from the previous line and new samplings and overlaps the previous line by 75 percent and the second line thus differs from the first one by one minute. Thereafter, a third line is achieved in the same way etc. until a complete period of interest may be presented.
- the data recording system is adapted so, that retractable kolyt electrodes with low polarization 22 are recording the EGG signals with 20 to 100 microvolt and transfer said signals to an impedance converter 20 with an amplifying factor 1.
- the signals are then sent to the data recording device 10 via an eight pin phone adapter 60, figure 2. Moreover, the signals are according to figure 2, after an analogue amplifying step with an optimal automatic offset 61 and an amplifying portion regulator 62, sent to an anologue/di- gital converter in the microprocessor unit 63.
- the sampling speed is set by the operative system (OS) and is controlled by means of a real time clock 64.
- OS operative system
- a RAM 65 is used to save data.
- the OS is programmed in a PROM 66.
- An ASIC-circuit is used for address decoding.
- the display 68 has 2 x 16 alfanumeric characters for recording the menue and the periodical values.
- the keyboard 69 is a board with four keys to control any menue events and patients events and for an automatic ON/OFF control.
- a contact 70 with 15 pins is the output channel to a computer or a printer 71.
- the voltage control unit 72 is supplied by a 9 volt standard alkali battery. As a part of this unit a chargeable litium battery is provided as a backup for the RAM 65 and the clock 64.
- a control circuit 73 takes care of any eventual absence of current by means of a NMI 74 and is also part of the current dsitribution system.
- the microprocessor unit 63 has six inputs with item 74 being ana ⁇ logue inputs, 76 and 77 are used for data and addresses, 78 and 79 are used for parallel communication and 80 is used for serial communica ⁇ tion.
- EGG based gastointestinal measurements also comple ⁇ mentary measurements/researches can be performed according to the invention to achieve improved diagnostic possibilities and a more reliable diagnosis.
- the EGG measurements are supplemented with impedance measurements with a larger or smaller number of sensors of a convenient type applied to the skin at interesting measuring spots, i.a. in connection to the EGG electrodes.
- gastric ultrasonis studies can be performed as a supple ⁇ ment, contractions and stomach emptying and bladder emptying possibly be detected by means of ultrasonics, the results being correlated with the EGG or EUG measurements.
- the measuring of high frequency vibrations according to GB-2,211,094 might also be performed as a supplement to the EGG measurements, any sound then being analyzed.
- a preferably portable or ambulatoric recording device for i.a. EGG data with an analysing system for said data can thus be used, a real time analysis then possibly being performed and presented to the device or dealt with afterwards by means of a computer and presented on the screen or by printed matter.
- EGG Digitrapper EGG Digitrapper
- EGG Digitrapper EGG Digitrapper
- This latter collects EGG sampling values from the patient antrum or corrsponding part, e.g. four times each second and stores the mean value each second in a digital memory.
- the patient can store events such as meals, etc.
- the stored values can be electrically transmitted to the examiner or in form of the device 10 and an analysis might be performed after a transmission to a computer or by means of the analysis system in the device.
- the invention also includes a special auto-offset and an automatic amplifying control to standardize the EGG signals from the patients with various stomach wall ticknesses, skin resistance, non identical electrode positions, etc.
- EGG measurements are combined with further measure ⁇ ments the results of these measurements are aslo recorded by means of the device, Digitrapper, and are used as a basis for a total analysis.
- the analysing system comprising pro ⁇ grams, the soft ware, is adapted to interpret the recorded signals in a fil ⁇ tered form and relate these to i.a. gastric performance.
- the system for an EGG analysis is preferably based on the Multigram Version 5.10 for motility procedures from Gastrosoft Inc., Irving, Texas, this version being essentially changed to analyse the EGG and to report the EGG function in such a form as to be clinically and scientifically usable.
- the main menue of the system cocmprises in one embodiment six choices: Patient Records, Read Digitrapper, Review Procedure, Print Report, System Constants and Quit.
- the system software is instructing the user to con ⁇ nect the Digitrapper to the computer with an interface cable and to place the Digitrapper in a communication mode.
- data are charged and stored automatically in a patient file on the computer hard disk.
- the user can print a standard analysis report by using the choice Print Report.
- Said report can be achieved by the choice Sys ⁇ tem Constants to be described here below.
- Design Pro ⁇ cedure provides the user with a screen with analysis periods to be selec ⁇ ted in accordance with appendix 2.
- the procedure can be formed further on the next screen which ap ⁇ pears when pressing the Page Down key.
- bradygastria and tachygastria and other conditions as well as selecting the software filter and amplifying factors can be ac ⁇ hieved on the screen according to appendix 3.
- Selecting -Desi n Diary shown in appendix 4 provides the user with the possibility to arrange the study in preselected periods.
- Selecting Set Environment permits the user to adapt the Path to the patient data file to specify the type of monitor to be used and to specify, if the scanned data are to be used and if a light signal should be on (to indicate to the user, that the connection between the Digitrapper and the computer during charging is not correct).
- Selecting Set Printer Parameter is shown in appendix 5 and let the user select a printer and configurate the size and the position of the writ ⁇ ten report.
- Selecting Back to Main Menue carries the user back to the main menue and selecting Quit in the main menue ends the programme.
- the invention provides essential advantages and new possibilities in comparison with what is known in the art.
- the invention provides improved diagnostic possibilities, an examination in the home, etc.
- said signals can thus be recorded in real time for a real time detection of a postsurgical or equivalent start of gas trie activity.
- said signals are recorded nonin- vasively or invasively and are correlated with an induced activity by means of a gastrointestinal pace maker, a desired pace maker influence then being adjusted on the base of a feedback information in form of said signals in the condition preferably achieved by means of said apparatus.
- the measuring with a refined technique according to the invention provides the possibility of a noninvasive detection of gastric stops and a phase detection.
- the data recording device 10 might thus in special applications be stationary or semistationary and not necessarily be portable or ambula- toric.
- the main application of the invention is however related to portable or ambulatory variations and its weight is preferably less than about 2 kg.
- the application of the method and the device according to the invention is not limited to the stomach, but other parts of the gastrointestinal part as well as the bladder, etc. can become the object for measurements etc. according to the invention.
- the patient wall impedance might be recor ⁇ ded this being achieved by recording electric signals related to said wall impedance, said signals providing the basis for a calibration/standardi ⁇ zation of the recorded gastric or corresponding depolarisation signals, preferably of the amplitude.
- the analysis system is conveninetly adapted to decide by means of a comparison with data for gastric activi ⁇ ty, if it has started and exists to such an extent that nourishment may be administered to the patient
- the result of a nourishment administration can in a corresponding way be decided under a corresponding or a similar condition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
A method primarily for electrogastography (EGG) of the gastrointestinal tract and electrourography (EUG) of the bladder including measuring of primarily rythmic depolarization signals of primarily gastrointestinal origin and/or vesical origin, electrodes (22) being applied to the patient and signals being detected by means of said electrodes. The method is especially characterized in that said signals, preferably in a filtered condition, are recorded by means of a portable data recording device (10) and are manipulated by means of the device directly mainly online and/or afterwards by means of the device and/or a computer (15) and are correlated to the gastrointestinal or urodynamic or corresponding condition of the patient. The invention also relates to a device for performing the method.
Description
O 96/10358 PC17SE95/01120
Method and device at primarily electrogastrography and e lee t rourogr aphy
The present invention relates a method for principally electrogast¬ rography (EGG) and electrourography (EUG) comprizing a measuring of principally rythmic depolarization signals of mainly a gastrointestinal origin or a vesical origin.
The invention also relates to a device for perfoπiiing the method.
Gastric depolarization signals normally occur with a frequency of about three cycles per minut. Other frequencies occur in other other parts. Some, but not all depolarization signals are considered to provoke gast¬ ric contractions, but all gastric contractions are considered, as also with EKG, to be preceded by electric depolarization signals. Inadequate depolarization signals might occur and it has proved that anormal signals occur with e.g. stomach suffering, such as indisposition, nervous bladder, incontinence, etc. Moreover, EGG presents thus a new way to achieve gastric motility with the advantage to be a noninvasive method to replace and/or complement other, more known methods, such as ultrasonics, gastric emptying, etc. Ambulatoric EGG can provide an easily usable, noninvasive and inexpensive method to analyse gastric activity e.g. in a domestic environment and can in the medical science facilitate a diag¬ nosis of gastric motility and to prescribe an adequate therapy.
In a corresponding way, EUG is a new method for a noninvasive examination of the urinary bladder. Here below the desciption is con¬ centrated to EGG, but all that may be stated in this respect is generally applicable even to EUG.
The detection of electrical cyclic signals from the stomach, i.e. EGG, was first achieved by Alvarez in 1922. Since then a variety of conditions, such as non explicable indisposition, indisposition during pregnancy, have been describes by mens of EGG.
EGG, however, has so far remained a research instrument adap¬ table for static and well defined conditions and applications, i.a. due to difficulties to measure feeble skin based EGG-signals in a well defined and unambiguous way.
The present invention provides the possibility for an accurate EGG in such a way that a diagnosis can be achieved with essentially improved
accuracy and stringency, the adaptation to research purposes thus being essentially increased. The improved diagnosis are, as is well known, en¬ tailing secondary advantages in form of a reduced convalescence, etc.
The invention thus relates to a method according to the first part of claim 1. The method is especially characterized in what is stated in the characterizing part of said claim.
The invention further relates to a device according to the first part of claim 8. The device is especially characterized in what is stated in the xharacterizing part of said last mentioned claim.
The invention is described in the following in connection to exe¬ cution examples and the attached drawings, on which
Figure 1 schematically shows the general configuration of a preferred embodiment of a portable system for EGG data recording according to the invention, and
Figure 2 shows a block diagram illustrating the overall logic circuit function of an EGG data recording device acccording to the invention.
In figure 1 the portable EGG and analyzing system comprises a data recording device 10 connected to external lines 11 ending in impe¬ dance converting electrodes 20 which then are connected to to skin based readable electrodes 22, preferably to at least two. The recording device is accomplished as a modification of the Digitrapper Mklll for recording pH-data (available from Synectics Medical Inc., Irving, Texas). A set of four keys 12 are adapted to control the data recording device and to let the patient register periodical data for events during recording. A display 13 cooperates to service the device 10 by (1) showing a menue driven control system during the preparation and the analys of the recording and (2) showing the recorded data on line during recording.
The impedance converting electrodes 20 comprize a field effect transistor circuit operating as an impedance converter with an amplifying factor 1. The electrodes 20 are connected to surface electrodes 22 placed on top of the patients stomach 23, small intestine, bladder, etc. The EGG or EUG signals are recorded and sent through said impedance converting
electrodes 20 and further through said lines 11 to the data recording device 10.
When the EGG or EUG recording operations are completed, data are sent from the device 10 into a computer 15, e.g. a PC, to analyze the recorded gastric signals as to the gastric function and generates a report of analysis (not shown). Alternatively, the device 10 may comprise a computer for a corresponding handling of said data.
In the report of analysis the relation between the postprandial and preprandial variables are presented, as well as the variable distribution and the values for bradygastria, normal frequency, tachygastria and duo¬ denal gastric activity. Frequency diagrams are shown for the various periods. The present program of analysis, the software, shows the spect¬ rum of variables from e.g. three prepandial periods and three postprandial periods. Moreover, the deviation from the fasting EGG activity is pre¬ sented during the born condition as a relation of the postprandial/prep- randial variables, as stated previously.
The standard report shows a spectrum of variables calculated by means of a fast frequency conversion, FFT, of the EGG signals from e.g. three preprandial periods and three selected postprandial periods. The recording device is sampling EGG data with a sampling freequency of about 2Hz during recording. These data are used and each line of the spectrum of variables uses 512 samplings during each cycle of four minutes. The X-axis shows the cycles per minut and the Y-axis the variable. The Z-axis shows the time intervals.
The next line of four minutes is using both the samplings from the previous line and new samplings and overlaps the previous line by 75 percent and the second line thus differs from the first one by one minute. Thereafter, a third line is achieved in the same way etc. until a complete period of interest may be presented.
Moreover, the distribution of variables between bradygastria, nor¬ mally three per minute, tachygastria and duodenal respiration patterns are presented for each period of interest.
Thus, it is i.a. possible to decide, if the pattern for a depolarization is normal or anormal, as with gastric paresis, indisposition of post ope¬ ration patients, etc.
Various periods of interest can be illustrated compared with a so-called normal period (basic period for the same patient) so that the patient in practice is used as his own standard level. The difference in the EGG pattern and the gastric activity between normal and anormal periods, with prokinetic medicine, between preprandial and postprandial periods (with a more regular pattern to probably occur during the post¬ prandial period) can thus be identified. Such differences between periods of gastric activity are then devided into columns of bradygastria, normal three per minut frequency, tachygastria and duodenal respiration.
The data recording system is adapted so, that retractable kolyt electrodes with low polarization 22 are recording the EGG signals with 20 to 100 microvolt and transfer said signals to an impedance converter 20 with an amplifying factor 1.
The signals are then sent to the data recording device 10 via an eight pin phone adapter 60, figure 2. Moreover, the signals are according to figure 2, after an analogue amplifying step with an optimal automatic offset 61 and an amplifying portion regulator 62, sent to an anologue/di- gital converter in the microprocessor unit 63.
The sampling speed is set by the operative system (OS) and is controlled by means of a real time clock 64.
A RAM 65 is used to save data.
The OS is programmed in a PROM 66. An ASIC-circuit is used for address decoding.
The display 68 has 2 x 16 alfanumeric characters for recording the menue and the periodical values.
The keyboard 69 is a board with four keys to control any menue events and patients events and for an automatic ON/OFF control.
A contact 70 with 15 pins is the output channel to a computer or a printer 71.
The voltage control unit 72 is supplied by a 9 volt standard alkali battery. As a part of this unit a chargeable litium battery is provided as a backup for the RAM 65 and the clock 64.
A control circuit 73 takes care of any eventual absence of current by means of a NMI 74 and is also part of the current dsitribution system.
The microprocessor unit 63 has six inputs with item 74 being ana¬ logue inputs, 76 and 77 are used for data and addresses, 78 and 79 are used for parallel communication and 80 is used for serial communica¬ tion.
Besides EGG based gastointestinal measurements also comple¬ mentary measurements/researches can be performed according to the invention to achieve improved diagnostic possibilities and a more reliable diagnosis.
Thus, the EGG measurements are supplemented with impedance measurements with a larger or smaller number of sensors of a convenient type applied to the skin at interesting measuring spots, i.a. in connection to the EGG electrodes.
Moreover, gastric ultrasonis studies can be performed as a supple¬ ment, contractions and stomach emptying and bladder emptying possibly be detected by means of ultrasonics, the results being correlated with the EGG or EUG measurements.
The measuring of high frequency vibrations according to GB-2,211,094 might also be performed as a supplement to the EGG measurements, any sound then being analyzed.
Moreover, measurements related to electric impedance tomography according to a method patented to Yvonne Magnall can be combined with EGG measurements.
The method according to the invention as well as its operation should be essentially evident from what is stated previously.
According to the invention, a preferably portable or ambulatoric recording device for i.a. EGG data with an analysing system for said data can thus be used, a real time analysis then possibly being performed and presented to the device or dealt with afterwards by means of a computer and presented on the screen or by printed matter.
Preferably special detachable skin based carbon electrodes with a low depolarization and a high stability are placed over the patient antrum and/or other places. One of the electrodes is connected directly to an im¬ pedance converter, a field effect transistor circuit, which in combination with a reference line from another electrode is connected to a digital EGG recording device (EGG Digitrapper). This latter collects EGG
sampling values from the patient antrum or corrsponding part, e.g. four times each second and stores the mean value each second in a digital memory. The patient can store events such as meals, etc. The stored values can be electrically transmitted to the examiner or in form of the device 10 and an analysis might be performed after a transmission to a computer or by means of the analysis system in the device. The invention also includes a special auto-offset and an automatic amplifying control to standardize the EGG signals from the patients with various stomach wall ticknesses, skin resistance, non identical electrode positions, etc. In the case the EGG measurements are combined with further measure¬ ments the results of these measurements are aslo recorded by means of the device, Digitrapper, and are used as a basis for a total analysis.
The analysing system according to the invention comprising pro¬ grams, the soft ware, is adapted to interpret the recorded signals in a fil¬ tered form and relate these to i.a. gastric performance. The system for an EGG analysis is preferably based on the Multigram Version 5.10 for motility procedures from Gastrosoft Inc., Irving, Texas, this version being essentially changed to analyse the EGG and to report the EGG function in such a form as to be clinically and scientifically usable.
The main menue of the system cocmprises in one embodiment six choices: Patient Records, Read Digitrapper, Review Procedure, Print Report, System Constants and Quit.
When a data recording device with gastric EGG signals has to be charged with the system software the choice Read Digitrapper is chosen and the patient data is filling the screen, according to appendix 1.
In the next step the system software is instructing the user to con¬ nect the Digitrapper to the computer with an interface cable and to place the Digitrapper in a communication mode. When this is performed, data are charged and stored automatically in a patient file on the computer hard disk.
However, if instead an already charged patient file will be the file of interest the user selects the choice Patient Record from the main menue and an already stored patient file is selected.
When a patient file first is stored in the computer via the choice
Patient Record or Read Digitrapper said raw EGG data can be overhaw- led and organized with the choice Review Procedure. In Review Proce¬ dure it is possible to modify certain periods as indicated by the patient when using one of the Patient Event keys 12 in the Digitrapper 10 during recording. New periods of interest can also be indicated, i.e. certain periods being regarded as normal for the patient and with which other periods (such as pain periods) might be compared. In this way the patient is acting as his own standard in the respect that deviations in the EGG activity can be analysed from said normal and anormal periods. Other periods to be compared in a similar way are preprandial and postprandial periods and a medium nightly activity with an early morning activity. When the user first has determined any periods of interest he might leave the choice Review by using the ESC key being always used for a back- staging in the main menue and to recreate the main menue screen.
Thereafter, the user can print a standard analysis report by using the choice Print Report. Said report can be achieved by the choice Sys¬ tem Constants to be described here below.
When selecting System Constants in the main menue it is possible to select any of the choices Design Procedure, Design Diary, Set Envi¬ ronment, Set Printer Parameters and Back to Main Menue. Design Pro¬ cedure provides the user with a screen with analysis periods to be selec¬ ted in accordance with appendix 2.
The procedure can be formed further on the next screen which ap¬ pears when pressing the Page Down key.
Definitions for bradygastria and tachygastria and other conditions as well as selecting the software filter and amplifying factors can be ac¬ hieved on the screen according to appendix 3.
Selecting -Desi n Diary shown in appendix 4 provides the user with the possibility to arrange the study in preselected periods.
Selecting Set Environment permits the user to adapt the Path to the patient data file to specify the type of monitor to be used and to specify, if the scanned data are to be used and if a light signal should be on (to indicate to the user, that the connection between the Digitrapper and the computer during charging is not correct).
Selecting Set Printer Parameter is shown in appendix 5 and let the user select a printer and configurate the size and the position of the writ¬ ten report.
Selecting Back to Main Menue carries the user back to the main menue and selecting Quit in the main menue ends the programme.
As evident from above the invention provides essential advantages and new possibilities in comparison with what is known in the art. Thus the invention provides improved diagnostic possibilities, an examination in the home, etc.
By means of the portable device said signals can thus be recorded in real time for a real time detection of a postsurgical or equivalent start of gas trie activity.
According to another application said signals are recorded nonin- vasively or invasively and are correlated with an induced activity by means of a gastrointestinal pace maker, a desired pace maker influence then being adjusted on the base of a feedback information in form of said signals in the condition preferably achieved by means of said apparatus.
The measuring with a refined technique according to the invention provides the possibility of a noninvasive detection of gastric stops and a phase detection.
The invention has been described above in connection with execu¬ tion examples and preferred embodiments. Various embodiments and minor changes can of course be envisaged without leaving the original spirit of the invention.
The data recording device 10 might thus in special applications be stationary or semistationary and not necessarily be portable or ambula- toric. The main application of the invention is however related to portable or ambulatory variations and its weight is preferably less than about 2 kg.
As should be evident from the preceding description the application of the method and the device according to the invention is not limited to the stomach, but other parts of the gastrointestinal part as well as the bladder, etc. can become the object for measurements etc. according to the invention.
As already mentioned the patient wall impedance might be recor¬ ded this being achieved by recording electric signals related to said wall impedance, said signals providing the basis for a calibration/standardi¬ zation of the recorded gastric or corresponding depolarisation signals, preferably of the amplitude.
For the determination in real time of a gastric start during postsur- gical conditions or corresponding the analysis system is conveninetly adapted to decide by means of a comparison with data for gastric activi¬ ty, if it has started and exists to such an extent that nourishment may be administered to the patient The result of a nourishment administration can in a corresponding way be decided under a corresponding or a similar condition.
Claims
1. A method primarily for electrogastrography (EGG) of the gast¬ rointestinal tract and electrourography (EUG) of the bladder including measuring or primarily rythmic depolarization signals of primarily gast¬ rointestinal origin and/or vesical origin, electrodes being applied to the patient and signals being detected by means of said electrodes, charac¬ terized in that said signals, preferably in a filtered condition, are recor¬ ded by means of a portable data recording device and are manipulated by means of the device directly mainly online and/or afterwards by means of the device and/or a computer and are correlated to the gastrointestinal or urodynamic or corresponding condition of the patient.
2. A method according to claim 1, characterized in that the cha¬ racteristics of the recorded signals are related to the patients condition, such as symptoms, uresis of a controlled or an uncontrolled type, post¬ prandial and preprandial conditions or events, etc, the patient in relevant cases himself providing the device with data of said conditions or events, etc.
3. A method according to claim 1 or 2, characterized in that said signals are treated and presented as one or several of the following vari¬ ables: a) the relation between postprandial and preprandial variables, b) the distribution of variables, c) bradygastric values, d) tachygastric values, e) values of duodengastric activity, g) the relation between symptomatic and nonsymptomatic periods related to the gastrointestinal tract and the bladder, h) vesical values before, during and after uresis.
4. A method according to claim 1, 2 or 3, characterized in that the recording of said signals is combined with any or several further measu¬ rements in the group of a) noninvasive measurements of the impedance, one or several pairs of skin based sensors being applied, by means of which said detected sig¬ nals are sent to said device, b) ultrasonic measurements for detecting emptying and contrations, c) measurements of high frequency surface vibrations according to GB2,211,094 of both the stomach and the bladder, d) electrical impedance tomography, e) stomach emptying with a gamma camera, f) measurements of the pressure in the gastrointestinal tract, the bladder or the uretrea, g)measurements by means of a laser and doppler effects.
5. A method according to claim 1, 2, 3 or 4, characterized in that said signals are recorded in real time for a real time analysis during an intensive care, a postsurgical, surgical or other diagnostic measuring of the gastrointestinal or bladder activity.
6. A method according to claim 1, 2, 3, 4 or 5, characterized in that said signals are recorded noninvasively or invasively and are corre¬ lated to an activity induced by a gastrointestinal or bladder pacemaker, the pacemaker effect being adjusted on the basis of a feedback informa¬ tion in form of said signals in a condition preferably treated by means of said apparatus.
7. A method according to claim 1, 2, 3, 4, 5 or 6, characterized in that electrical signals correlated to the patient wall impedance are recor¬ ded and are used as a basis for a calibration/standardization of the recor¬ ded gastric depolarization signals or bladder depolarizations signals, preferably of the amplitude.
8. A device primarily for electrogastrography (EGG) of the gastro¬ intestinal tract and electrourography (EUG) of the bladder including measuring or primarily rythmic depolarization signals of primarily gast¬ rointestinal origin and/or vesical origin, including electrodes to be app¬ lied to the patient and to detect said signals, characterized in that a pre¬ ferably portable data recording device (10) is adapted for recording said signals, preferably in a filtered condition, said signals being adapted to be treated by means of said device mainly online and/or afterwards by means of said device and/or a computer to be correlated to the gastroin¬ testinal or vesical or a corresponding condition of the patient.
9. A device according to claim 1, said measurements being prefer¬ ably noninvasive, characterized in a) at least two circuit electrodes for impedance converter field effect transistors, b) two skin based electrodes with a low polarization, each being applied to each such an impedance converting electrode, c) a portable and in adaptable cases ambulatory data recording device, d) electricity conducting devices as a connection between each such an impedance converting electrode and said data recording device.
10. A device according to claim 8 or 9, characterized in devices for measuring the abdominal wall impedance of patients and to generate electric signals correlated to said impedance and electricity conducting devices as a connection between the devices for measuring the wall im¬ pedance and said data recording device.
11. A device according to claim 10, characterized in that devices are provided for treating such impedance signals to select an amplifica¬ tion factor for an automatic control of the gain and the offset of such gastric depolarization signals to achieve a standard amplitude for such gastric depolarization signals.
12. A device according to claim 9, 10 or 11, characterized in a) a number of amplifiers and a number of filters for such gastointestinal signals and vesical signals, b) a keyboard enabling the generating registeration of patient related event signals of the patient, c) a digital display.
13. A device according to claim 9, 10, 11 or 12, characterized in that the data recording device is adapted to receive signals from comp¬ lementary measurements adapted to be combined with said depolariza¬ tion signals to evaluate the gastrointestinal condition and/or the vesical condition of the patient, such as indisposition, gastroparesis, gastrointes¬ tinal obstruction, stomach emptying speed, incontinence, nervous blad¬ der, neuropathy, etc.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU36246/95A AU3624695A (en) | 1994-09-30 | 1995-10-02 | Method and device at primarily electrogastrography and electrourography |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403321A SE9403321D0 (en) | 1994-09-30 | 1994-09-30 | Procedure and apparatus for remote electrogastrography |
SE9403321-4 | 1994-09-30 | ||
SE9403344-6 | 1994-10-03 | ||
SE9403344A SE9403344L (en) | 1994-09-30 | 1994-10-03 | Procedure and apparatus for mainly electrogastrography and electrourography |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996010358A1 true WO1996010358A1 (en) | 1996-04-11 |
Family
ID=26662145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1995/001120 WO1996010358A1 (en) | 1994-09-30 | 1995-10-02 | Method and device at primarily electrogastrography and electrourography |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3624695A (en) |
SE (1) | SE9403344L (en) |
WO (1) | WO1996010358A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0965303A3 (en) * | 1998-06-15 | 2000-09-13 | Gram Corporation | Electrogastrograph and method for analyzing data obtained by the electrogastrograph |
US6947792B2 (en) | 1997-07-16 | 2005-09-20 | Impulse Dynamics N.V. | Smooth muscle controller |
US7006871B1 (en) | 1997-07-16 | 2006-02-28 | Metacure N.V. | Blood glucose level control |
EP1182967A4 (en) * | 1999-05-07 | 2009-03-25 | Kenneth L Koch | Method and apparatus for evaluating myoelectric signals and identifying artifact |
US20130046150A1 (en) * | 2010-11-01 | 2013-02-21 | G-Tech | Method for diagnosis and treatment of disorders of the gastrointestinal tract, and apparatus for use therewith |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US8958872B2 (en) | 1996-01-08 | 2015-02-17 | Impulse Dynamics, N.V. | Electrical muscle controller |
US8977353B2 (en) | 2004-03-10 | 2015-03-10 | Impulse Dynamics Nv | Protein activity modification |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US9931503B2 (en) | 2003-03-10 | 2018-04-03 | Impulse Dynamics Nv | Protein activity modification |
US9943264B2 (en) | 2012-10-10 | 2018-04-17 | G-Tech Medical, Inc. | Wearable wireless patches containing electrode pair arrays for gastrointestinal electrodiagnostics |
US10485444B2 (en) | 2014-10-17 | 2019-11-26 | G-Tech Medical, Inc. | Systems and methods for processing electromyographic signals of the gastrointestinal tract |
US10499829B2 (en) | 2010-11-01 | 2019-12-10 | G-Tech Medical, Inc. | Wearable wireless patches containing electrode pair arrays for gastrointestinal electrodiagnostics |
US10512414B2 (en) | 2015-08-29 | 2019-12-24 | G-Tech Medical, Inc. | Apparatus and method for detecting gastrointestinal motor activity during post-operative recovery |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
US11826170B2 (en) | 2012-10-10 | 2023-11-28 | G-Tech Medical, Inc. | Artificial intelligence models for wireless patch data acquisition for gastrointestinal electrodiagnostics |
US12178580B2 (en) | 2019-12-23 | 2024-12-31 | Alimetry Limited | Electrode patch and connection system |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2210713A (en) * | 1987-10-02 | 1989-06-14 | Intelligent Decision Systems S | Installation for assisting the diagnosis of cardiovascular and pulmonary pathologies |
WO1992006634A1 (en) * | 1990-10-18 | 1992-04-30 | Centrum för Dentalteknik och Biomaterial | A device for measurement of electrical impedance of organic and biological materials |
CN1079379A (en) * | 1993-03-04 | 1993-12-15 | 中国科学院合肥分院 | Novel gastrointestinal electric signal detection processing device and method |
WO1994001172A1 (en) * | 1992-07-10 | 1994-01-20 | Douglas Donald D | A percutaneously placed electrical intestinal pacemaker |
-
1994
- 1994-10-03 SE SE9403344A patent/SE9403344L/en not_active Application Discontinuation
-
1995
- 1995-10-02 WO PCT/SE1995/001120 patent/WO1996010358A1/en active Application Filing
- 1995-10-02 AU AU36246/95A patent/AU3624695A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2210713A (en) * | 1987-10-02 | 1989-06-14 | Intelligent Decision Systems S | Installation for assisting the diagnosis of cardiovascular and pulmonary pathologies |
WO1992006634A1 (en) * | 1990-10-18 | 1992-04-30 | Centrum för Dentalteknik och Biomaterial | A device for measurement of electrical impedance of organic and biological materials |
WO1994001172A1 (en) * | 1992-07-10 | 1994-01-20 | Douglas Donald D | A percutaneously placed electrical intestinal pacemaker |
CN1079379A (en) * | 1993-03-04 | 1993-12-15 | 中国科学院合肥分院 | Novel gastrointestinal electric signal detection processing device and method |
Non-Patent Citations (1)
Title |
---|
DATABASE CHINESE PATENT ABSTRACTS IN ENGLISH ON DIALOG, Week 9533, INPADOC, (Vienna, Austria), No. 4049378; & CN,A,1 079 379, (HEFEI DIVISION CHINESE ACADEMY). * |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8958872B2 (en) | 1996-01-08 | 2015-02-17 | Impulse Dynamics, N.V. | Electrical muscle controller |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9186514B2 (en) | 1996-01-08 | 2015-11-17 | Impulse Dynamics Nv | Electrical muscle controller |
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US7221978B2 (en) | 1997-07-16 | 2007-05-22 | Metacure Nv | Smooth muscle controller |
US6947792B2 (en) | 1997-07-16 | 2005-09-20 | Impulse Dynamics N.V. | Smooth muscle controller |
US7120497B2 (en) | 1997-07-16 | 2006-10-10 | Metacure Nv | Smooth muscle controller |
US9265930B2 (en) | 1997-07-16 | 2016-02-23 | Metacure Limited | Methods and devices for modifying vascular parameters |
US7006871B1 (en) | 1997-07-16 | 2006-02-28 | Metacure N.V. | Blood glucose level control |
EP0965303A3 (en) * | 1998-06-15 | 2000-09-13 | Gram Corporation | Electrogastrograph and method for analyzing data obtained by the electrogastrograph |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
EP1182967A4 (en) * | 1999-05-07 | 2009-03-25 | Kenneth L Koch | Method and apparatus for evaluating myoelectric signals and identifying artifact |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US9931503B2 (en) | 2003-03-10 | 2018-04-03 | Impulse Dynamics Nv | Protein activity modification |
US10352948B2 (en) | 2004-03-10 | 2019-07-16 | Impulse Dynamics Nv | Protein activity modification |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
US9440080B2 (en) | 2004-03-10 | 2016-09-13 | Impulse Dynamics Nv | Protein activity modification |
US8977353B2 (en) | 2004-03-10 | 2015-03-10 | Impulse Dynamics Nv | Protein activity modification |
US12268882B2 (en) | 2004-12-09 | 2025-04-08 | Impulse Dynamics Nv | Beta blocker therapy with electrical administration |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US10499829B2 (en) | 2010-11-01 | 2019-12-10 | G-Tech Medical, Inc. | Wearable wireless patches containing electrode pair arrays for gastrointestinal electrodiagnostics |
US11432759B2 (en) | 2010-11-01 | 2022-09-06 | G-Tech | Method for diagnosis and treatment of disorders of the gastrointestinal tract, and apparatus for use therewith |
US9474482B2 (en) * | 2010-11-01 | 2016-10-25 | G-Tech Medical, Inc. | Method for diagnosis and treatment of disorders of the gastrointestinal tract, and apparatus for use therewith |
US20130046150A1 (en) * | 2010-11-01 | 2013-02-21 | G-Tech | Method for diagnosis and treatment of disorders of the gastrointestinal tract, and apparatus for use therewith |
US9943264B2 (en) | 2012-10-10 | 2018-04-17 | G-Tech Medical, Inc. | Wearable wireless patches containing electrode pair arrays for gastrointestinal electrodiagnostics |
US11826170B2 (en) | 2012-10-10 | 2023-11-28 | G-Tech Medical, Inc. | Artificial intelligence models for wireless patch data acquisition for gastrointestinal electrodiagnostics |
US10485444B2 (en) | 2014-10-17 | 2019-11-26 | G-Tech Medical, Inc. | Systems and methods for processing electromyographic signals of the gastrointestinal tract |
US11826157B2 (en) | 2014-10-17 | 2023-11-28 | G-Tech Medical, Inc. | Systems and methods for processing electromyographic signals of the gastrointestinal tract |
US10512414B2 (en) | 2015-08-29 | 2019-12-24 | G-Tech Medical, Inc. | Apparatus and method for detecting gastrointestinal motor activity during post-operative recovery |
US12178580B2 (en) | 2019-12-23 | 2024-12-31 | Alimetry Limited | Electrode patch and connection system |
US12245862B2 (en) | 2019-12-23 | 2025-03-11 | Alimetry Limited | Electrode patch and connection system |
Also Published As
Publication number | Publication date |
---|---|
SE9403344L (en) | 1996-03-31 |
AU3624695A (en) | 1996-04-26 |
SE9403344D0 (en) | 1994-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996010358A1 (en) | Method and device at primarily electrogastrography and electrourography | |
Gharibans et al. | A novel scalable electrode array and system for non‐invasively assessing gastric function using flexible electronics | |
O'Grady et al. | Methods for high-resolution electrical mapping in the gastrointestinal tract | |
EP0284685A2 (en) | Apparatus and method for detecting and processing bioelectric signals | |
US20060167367A1 (en) | Method and system for collecting data on a plurality of patients | |
WO1997024980A1 (en) | Bioenergetic data collection apparatus | |
WO1997017012A9 (en) | Modular physiological computer-recorder | |
WO1997017012A1 (en) | Modular physiological computer-recorder | |
EP1638458A2 (en) | Device and method for an automated e.e.g. system for auditory evoked responses | |
CN1426287A (en) | Portable ECG signaling device | |
US20090177048A1 (en) | Miniature, wireless apparatus for processing physiological signals and use thereof | |
JP4783782B2 (en) | Intelligent self-interpreting visceral electromyogram system and method | |
US5123419A (en) | Combined pacemaker parameter and vital sign monitor and method of display | |
TWI225394B (en) | Method and device for analysis of heart rate variability (HRV) | |
Nandagopal et al. | Newly constructed real time ECG monitoring system using labview | |
CN1252627C (en) | Measurement data processing system | |
US20050059900A1 (en) | Method and apparatus for measuring bladder electrical activity to diagnose bladder dysfunction | |
Brucal et al. | Portable electrocardiogram device using Android smartphone | |
Ardila et al. | Digital ECG Phantom Design to Represent the Human Heart Signal for Early Test on ECG Machine in Hospital | |
JPH05161611A (en) | Medical telemeter device | |
WO2005051201A1 (en) | Monitoring of neuromuscular blockade using phonomyography | |
RU2076625C1 (en) | Device for examination of brain biological activity | |
KR100971341B1 (en) | Expert self-interpretation electronic embedded imaging system and method | |
Antonenko et al. | Development of signal generator for calibrating ECG devices | |
EP1969999B1 (en) | Miniature, wireless apparatus for processing physiological signals and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |